The purpose of this note is to correct both the analysis and typographical errors.

The typos are as follows. The abstract, line 6: In "in 6 patients (8%)" should read "in 5 patients (6%)". Page 4, line 12: In "8% (6) of the samples, being 5 *missens*" should read "6% (5) of the samples, being 4 *missense*". Page 4, line 19: In "Of the 6 cases" should read "Of the 5 cases". Page 4, line 20: In "(5, or 83.3%)" should read "(4, or 80%)". Page 4, second column, line 8: In "OS for patients with wild *DNMT3A* gene was 41.4% and for patients with mutated *DNMT3A* was 44.4% (*P* = 0.59)" should read "OS for patients with wild *DNMT3A* gene was 45.7% and for patients with mutated *DNMT3A* was 60.0% (*P* = 0.47)". Page 6, line 4: In "found in 8%" should read "found in 6%". Page 6, second column, line 13: In "3 of 6 mutations" should read "3 of 5 mutations". Page 6, second column, line 16: In "Five, or 80%," should read "Four, or 80%,". Page 6, second column, line 18: In "(*P* = 0.28)" should read "(*P* = 0.34)". Page 6, second column, line 20: In "(20.7 × 10^9^/L)" should read "(15.6 × 10^9^/L)". [Table 4](#tab4){ref-type="table"}, column 2, line 6: In "H896\*" should read "P896\*". [Table 4](#tab4){ref-type="table"}: Entire line 7 was excluded. [Table 5](#tab5){ref-type="table"}, line 2: In "40.2, 44.8 and 0.56" should read "47.4, 40.4 and 0.42". [Table 5](#tab5){ref-type="table"}, line 4: In "50% (3), 59.3% (45) and 0.68" should read "60% (3), 57.9% (44) and 0.92". [Table 5](#tab5){ref-type="table"}, line 5: In "50% (3), 40.7% (31)" should read "40% (2), 42.1% (32)". [Table 5](#tab5){ref-type="table"}, line 19: In "50% (3), 51.4% (37) and 1.000" should read "40% (2), 52.7% (39) and 0.66". [Table 5](#tab5){ref-type="table"}, line 20: In "50% (2), 30.9% (17) and 0.58" should read "40% (2), 29.2% (21) and 0.63". We changed [Figure 3](#fig3){ref-type="fig"} as shown above.
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###### 

Description of somatic mutations found in gene *DNMT3A*.

  Patient identification   Mutation   Allelic change   Exon   Type of mutation   FAB subtype   PCR          Risk group     Karyotype
  ------------------------ ---------- ---------------- ------ ------------------ ------------- ------------ -------------- ----------------
  39                       D748N      G \> A           19     *Missense*         M1            Negative     Intermediate   Normal
  79                       R882H      G \> A           23     *Missense*         M1            Negative     Intermediate   Trisomy (8)(9)
  4                        R882H      G \> A           23     *Missense*         M3            Negative     Intermediate   Normal
  70                       R882H      G \> A           23     *Missense*         M2            Negative     Intermediate   Normal
  41                       P896\*     A \> G           23     *Silent*           M3            PML/RAR*α*   Favorable      t(15;17)

###### 

Clinical characteristics of patients with Acute Myeloid Leukemia with or without *DNMT3A* mutations.

  Characteristics                Number of pts (%) *DNMT3A* mutated   Number of pts (%) *DNMT3A* not mutated   *P*
  ------------------------------ ------------------------------------ ---------------------------------------- -------
  Age (median)                   47.4                                 40.4                                     0.42
  Sex                                                                                                           
   Male                          60% (3)                              57.9% (44)                               0.92
   Female                        40% (2)                              42.1% (32)                               
  Subtype FAB                                                                                                   
   M0                            0%                                   7.2%  (5)                                 
   M1                            60%  (3)                             18.8%  (13)                               
   M2                            20%  (1)                             30.4%  (21)                              0.56
   M3                            20%  (1)                             20.3%  (14)                              
   M4                            0%                                   18.8%  (13)                               
   M5                            0%                                   1.4%  (1)                                 
   Not M3                        0%                                   2.9%  (2)                                 
  Risk groups                                                                                                   
   Favorable                     20%  (1)                             29.8%  (17)                               
   Intermediate                  80%  (4)                             59.6%  (34)                              1.000
   Unfavorable                   0%                                   10.5%  (6)                                
  Leukocytes (×10^3^) (median)   20.67                                6.41                                     0.28
  Death                          40% (2)                              52.7% (39)                               0.66
  Relapses                       40% (2)                              29.2% (21)                               0.63
  Refractory                     20%  (1)                             19.1%  (13)                              0.96
